EW vs. GH: Edwards Lifesciences vs. Guardant Health Stock Comparison
How do Edwards Lifesciences (EW) and Guardant Health (GH) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Edwards Lifesciences (EW) and Guardant Health (GH) both fall under the Health Care Equipment & Services industry group, but EW is classified in Health Care Equipment & Supplies while GH is classified in Health Care Providers & Services.
| Profile Item | EW | GH |
|---|---|---|
| Name | Edwards Lifesciences Corporation | Guardant Health, Inc. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Providers & Services |
| GICS Sub-Industry | Health Care Equipment | Health Care Services |
| Market Capitalization | 58.73 billion USD | 20.41 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | Nasdaq |
| Listing Date | March 27, 2000 | October 4, 2018 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | EW | GH |
|---|---|---|
| Total Return (1Y) | 25.08% | 66.53% |
| Total Return (3Y, Annualized) | 17.28% | 92.76% |
| Total Return (5Y, Annualized) | -2.77% | 8.36% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | EW | GH |
|---|---|---|
| Volatility (1Y, Annualized) | 25.58% | 53.23% |
| Beta (5Y) | 0.78 | 1.69 |
| Max Drawdown (5Y) | -54.32% | -85.09% |
| Avg. Volume (3M) | 3.69M | 1.97M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | EW | GH |
|---|---|---|
| Sharpe Ratio (1Y) | 0.81 | 1.17 |
| Sortino Ratio (1Y) | 1.23 | 1.84 |
Profitability
ROE (TTM)
Capital efficiency shows on one side only: Edwards Lifesciences (EW) earns 9.33% on shareholders’ equity, ranked against its industry; Guardant Health (GH) has no ROE this period.
EW
Health Care Equipment & Services industry group
9.33%
- Max
- 47.61%
- Q3
- 14.36%
- EW
- 9.33%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
GH
Health Care Equipment & Services industry group
--
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
- GH
- --
Net Margin (TTM)
Guardant Health (GH) reports a negative net margin of -37.93%, usually indicating a net loss over the period. Meanwhile Edwards Lifesciences (EW) reports 15.30%, ranking against industry peers normally.
EW
Health Care Equipment & Services industry group
15.30%
- Max
- 29.35%
- EW
- 15.30%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
GH
Health Care Equipment & Services industry group
-37.93%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
- GH
- -37.93%
Operating Margin (TTM)
Guardant Health (GH) reports a negative operating margin of -37.06%, usually indicating that operating costs exceeded revenue at the operating-income line. Meanwhile Edwards Lifesciences (EW) reports 30.15%, ranking against industry peers normally.
EW
Health Care Equipment & Services industry group
30.15%
- Max
- 35.43%
- EW
- 30.15%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
GH
Health Care Equipment & Services industry group
-37.06%
- Max
- 35.43%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
- GH
- -37.06%
Profitability Metrics
| Metric | EW | GH |
|---|---|---|
| ROE (TTM) | 9.33% | -- |
| ROA (TTM) | 8.77% | -19.92% |
| Net Margin (TTM) | 15.30% | -37.93% |
| Operating Margin (TTM) | 30.15% | -37.06% |
| Gross Margin (TTM) | 78.02% | 65.19% |
Growth
Revenue Growth
Guardant Health (GH) at 32.88% sits in the top revenue growth quartile, while Edwards Lifesciences (EW) at 11.55% is closer to the peer norm — faster top-line expansion for GH.
EPS Growth
Only one side can be read here: Edwards Lifesciences (EW) reports EPS growth of -73.74%, ranked against its industry; Guardant Health (GH) has no EPS growth figure this period.
Growth Metrics
| Metric | EW | GH |
|---|---|---|
| Revenue Growth (YoY) | 11.55% | 32.88% |
| Revenue Growth (3Y CAGR) | 10.77% | 29.75% |
| EPS Growth (YoY) | -73.74% | -- |
| EPS Growth (3Y CAGR) | -9.14% | -- |
Financial Strength
Current Ratio (MRQ)
Guardant Health (GH) at 3.60 keeps current ratio within its industry’s typical mid-range, while Edwards Lifesciences (EW) at 4.60 sits above its industry’s typical mid-range — comfortable liquidity, though possibly with more idle current assets relative to peers.
EW
Health Care Equipment & Services industry group
4.60
- Max
- 7.59
- EW
- 4.60
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
GH
Health Care Equipment & Services industry group
3.60
- Max
- 7.59
- Q3
- 4.00
- GH
- 3.60
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Only one side’s leverage can be read here: Edwards Lifesciences (EW) carries debt-to-equity ratio of 0.06 against its industry range, while Guardant Health (GH) reports no figure this period.
EW
Health Care Equipment & Services industry group
0.06
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- EW
- 0.06
- Min
- 0.00
GH
Health Care Equipment & Services industry group
--
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
- GH
- --
Financial Strength Metrics
| Metric | EW | GH |
|---|---|---|
| Current Ratio (MRQ) | 4.60 | 3.60 |
| Debt / Equity (MRQ) | 0.06 | -- |
| Net Debt / EBITDA | -1.88 | -- |
Dividends
Dividend Yield (TTM)
Neither Edwards Lifesciences (EW) nor Guardant Health (GH) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
EW
Health Care Equipment & Services industry group
0.00%
- EW
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
GH
Health Care Equipment & Services industry group
0.00%
- GH
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Neither Edwards Lifesciences (EW) nor Guardant Health (GH) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
EW
Health Care Equipment & Services industry group
0.00%
- EW
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
GH
Health Care Equipment & Services industry group
0.00%
- GH
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | EW | GH |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
P/E Ratio (TTM)
An earnings multiple is available for just one side: Edwards Lifesciences (EW) trades at 59.38 times trailing earnings, ranked against its peers, while Guardant Health (GH) has no P/E ratio this period.
EW
Health Care Equipment & Services industry group
59.38
- Max
- 80.41
- EW
- 59.38
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
GH
Health Care Equipment & Services industry group
--
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
- GH
- --
P/S Ratio (TTM)
Both look expensive on sales: Edwards Lifesciences (EW) at 8.80 sits in the upper P/S ratio quartile, and Guardant Health (GH) at 15.96 prices even higher, above its industry range.
EW
Health Care Equipment & Services industry group
8.80
- EW
- 8.80
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
GH
Health Care Equipment & Services industry group
15.96
- GH
- 15.96
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
Guardant Health (GH) reports a negative P/B ratio of -73.67, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile Edwards Lifesciences (EW) reports 5.41, ranking against industry peers normally.
EW
Health Care Equipment & Services industry group
5.41
- Max
- 11.68
- Q3
- 6.12
- EW
- 5.41
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
GH
Health Care Equipment & Services industry group
-73.67
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
- GH
- -73.67
Valuation Metrics
| Metric | EW | GH |
|---|---|---|
| P/E Ratio (TTM) | 59.38 | -- |
| P/S Ratio (TTM) | 8.80 | 15.96 |
| P/B Ratio (MRQ) | 5.41 | -73.67 |
| Free Cash Flow Yield (TTM) | 1.95% | -0.30% |